市場調查報告書
商品編碼
1492344
大麻酚市場:按產品類型、來源、應用、分銷管道分類 - 全球預測 2024-2030Cannabinol Market by Product Type (Capsules & Softgels, Edibles, Oils & Tinctures), Source (Non-Organic, Organic), Application, Distribution Channel - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年大麻酚市場規模為86.9億美元,預計2024年將達到95.7億美元,2030年將達到172.4億美元,複合年成長率為10.28%。
大麻酚是大麻植物中天然存在的化合物,是由四氫大麻酚 (THC) 分解產生的,四氫大麻酚是大麻中發現的化合物,常見於較舊的大麻產品中。大麻酚 (CBN) 市場專注於用於治療和健康應用的 CBN 注入產品的生產、分銷和銷售,例如藥品、健康產品、化妝品和營養食品。該市場迎合各種最終用戶的需求,包括醫療保健提供者、健康愛好者和尋求自然緩解選擇的普通消費者。社會對 CBN 潛在治療作用的認知不斷提高,以及對自然療法的興趣日益濃厚,正在推動全球對大麻酚的需求。然而,高昂的生產成本、市場上仿冒品氮化硼產品的存在以及產品召回的普遍存在阻礙了市場的成長。此外,增加對研究和創新的投資,包括證明治療功效的大規模臨床試驗、產品輸送機制的進步以及永續的培養和提取方法,將推動CBN 市場的顯著成長,其成長潛力使其成為令人興奮的市場。
主要市場統計 | |
---|---|
基準年[2023] | 86.9億美元 |
預測年份 [2024] | 95.7億美元 |
預測年份 [2030] | 172.4億美元 |
複合年成長率(%) | 10.28% |
區域洞察
全球大麻酚市場呈現不同地區的不同法規環境和消費者利益。在北美和南美,特別是美國,隨著消費者對立方氮化硼作為助眠劑和放鬆產品的成分越來越感興趣,該市場正在快速成長。該地區的大麻和醫療保健法規正在不斷發展,促進了充滿活力的市場環境。憑藉大麻合法化框架,加拿大為大麻素研究和商業活動創造了有利的環境,推動了消費者對含立方氮化硼健康產品的強烈偏好。美國和加拿大的消費者對健康和天然保健產品有著濃厚的興趣,推動了高需求和顯著的市場活動。在歐洲、中東和非洲地區,消費者的需求和行為因監管環境而異。在健康趨勢的推動下,歐洲對 CBN 的興趣日益濃厚。在中東,由於嚴格的監管,市場活動受到限制,而在非洲,興趣主要集中在南非。在亞太地區,特別是在中國、日本和印度等國家,法律體制的逐步變化和意識的提高正在推動大麻酚的需求。對大麻酚健康益處的研究和開發正在推動該地區對大麻酚的需求。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在大麻酚市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對大麻酚市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對大麻酚市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[194 Pages Report] The Cannabinol Market size was estimated at USD 8.69 billion in 2023 and expected to reach USD 9.57 billion in 2024, at a CAGR 10.28% to reach USD 17.24 billion by 2030.
Cannabinol is a naturally occurring compound in the cannabis plant that is created as a result of the degradation of tetrahydrocannabinol (THC), the compound in cannabis, and is typically present in older cannabis products. The cannabinol (CBN) market is focused on producing, distributing, and selling CBN-infused products aimed at therapeutic and wellness applications, including pharmaceuticals, wellness products, cosmetics, and nutraceuticals. The market caters to various end-users, such as healthcare providers, wellness enthusiasts, and everyday consumers seeking natural relief options. The increasing public awareness of CBN's potential therapeutic benefits and the rising interest in natural therapies drive the global demand for cannabinol. However, high production costs, the presence of counterfeit CBN products in the market, and the prevalence of product recalls hinder market growth. Moreover, with increased investment in research and innovation, including extensive clinical trials to substantiate therapeutic claims, advancements in product delivery mechanisms, and sustainable cultivation and extraction practices, the CBN market has substantial growth potential, making it a noteworthy sector within wellness and pharmaceuticals.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.69 billion |
Estimated Year [2024] | USD 9.57 billion |
Forecast Year [2030] | USD 17.24 billion |
CAGR (%) | 10.28% |
Regional Insights
The global cannabinol market showcases diverse regulatory environments and consumer interests across different regions. In the Americas, particularly the United States, the market is burgeoning with growing consumer interest in CBN as a component of sleep aids and relaxation products, propelled by a significant number of patents and robust investment in research and product development. The evolving regulations regarding cannabis and healthcare in the region contribute to the dynamic market landscape. Canada, with its legalized cannabis framework, fosters a conducive environment for cannabinoid research and commercial activities, driving a strong consumer preference for wellness products containing CBN. Consumers in the U.S. and Canada have a strong interest in wellness and natural health products, driving high demand and significant market activities. In EMEA, consumer needs and behaviors vary widely depending on the regulatory landscape. Europe shows a growing interest in CBN, driven by the wellness trend. The Middle East displays limited market activities due to strict regulations, while Africa shows nascent interest, with actions concentrated mainly in South Africa. In Asia Pacific, particularly in countries includin China, Japan, and India, the gradual changes in legal frameworks and increasing awareness increase the demand for cannabinol. Research and development initiatives regarding the health benefits of cannabinol within the region drive the demand for cannabinol.
Market Insights
The market dynamics represent an ever-changing landscape of the Cannabinol Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cannabinol Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cannabinol Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
CV Sciences Expands PlusCBD Pet Product Line with New Pet Chews
CV Sciences, Inc. announced the expansion of its PlusCBD pet product offerings with the introduction of new pet chews. This addition aims to cater to the growing demand for natural pet supplements that support overall wellness. These new products support the company's commitment to improving the quality of life for pets through scientifically backed, high-quality CBD solutions. [Published On: 2024-03-26]
Launch of Synthetic CBD by Healthcare Firm Marks Significant Advancement in Epilepsy Treatment
Akumentis Healthcare introduced a synthetic form of CBD targeted at managing epilepsy, marking a noteworthy innovation in medical treatments. The launch emphasizes the increasing acceptance and integration of cannabinoid-based therapies in mainstream medicine, offering new hope for patients afflicted with seizure disorders. [Published On: 2024-01-11]
Zenara Receives Approval for Cannabidiol to Treat Neurological Disorders
Zenara received regulatory approval for its cannabidiol product, which is aimed at treating various neurological disorders. This decision represents a significant medical and pharmaceutical industry advance, opening doors for new therapeutic options for patients with neurological conditions. This development emphasizes the growing acceptance and integration of cannabinoid-based treatments in mainstream healthcare. [Published On: 2023-05-15]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cannabinol Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cannabinol Market, highlighting leading vendors and their innovative profiles. These include AURORA CANNABIS INC., CHARLOTTE'S WEB, INC., CV Sciences, Inc., Diamond CBD, Elixinol Wellness Limited, ENDOCA., Etz Hayim Holdings, SPC, Folium Biosciences Europe B.V., Gaia Botanicals, LLC, Gaia Herbs, Inc., Green Roads, High Labs International Inc., Isodiol International Inc., Medical Marijuana, Inc., Medterra CBD, LLC, NuLeaf Naturals, LLC, PharmaHemp d.o.o., and Shaman Botanicals LLC.
Market Segmentation & Coverage